MEDecision Webinar to Examine How Technology Can Help Health Plans Navigate Changing Healthcare Mandates

Session Will Feature Alineo 3.0, the Latest Version of MEDecision’s Alineo Collaborative Healthcare Management Platform

WAYNE, Pa.--(BUSINESS WIRE)-- MEDecision, Inc., a leading provider of collaborative healthcare management solutions, will conduct a complimentary webinar highlighting technology that enables health plans to meet changing healthcare regulations. The session is scheduled for Wednesday, September 15 at 12:30 p.m. Eastern time, and will be hosted by MEDecision’s Director of Product Marketing Deepika Singh and Clinical Product Manager Pat Sitko.

The webinar will focus on Alineo® 3.0, the latest version of MEDecision’s Alineo collaborative healthcare management platform. Alineo 3.0 features a new behavioral health utilization module designed to support the requirements of the 2008 Federal Mental Health Parity and Addiction Equity Act, and various enhancements to help health plans facilitate more timely and accurate decision making to improve outcomes, increase clinical consistency and reduce costs. Attendees will learn how organizations can leverage the technology to optimally navigate the market’s rapidly evolving regulatory landscape by using it to:

  • Better classify and manage patients for a more holistic patient view
  • Improve the coordination of care between patients, payers and providers
  • Provide additional data capture for member benefits and quality and compliance purposes
  • Improve workflow and approval processing to ultimately reduce administrative cost

What:

  MEDecision webinar: “Introduction to Alineo 3.0”
 

Who:

MEDecision’s Director of Product Marketing Deepika Singh and Clinical Product Manager Pat Sitko
 

When:

Wednesday, September 15, 2010; 12:30 p.m. Eastern time (9:30 a.m. Pacific time)
 

How:

Register at www.MEDecision.com/webinar.

 

For more information about MEDecision, please visit www.MEDecision.com. Follow the company on Twitter at @MEDecision and on Facebook at www.MEDecision.com/Facebook.

About MEDecision

MEDecision offers collaborative healthcare management solutions that provide a simple and smart way for payers and providers to harness the power of knowledge to enable the best clinical decisions and improve health outcomes. Designed around a patient-aware health management philosophy, MEDecision’s solutions include Alineo®, a collaborative healthcare management platform for delivering outcome-driven case, disease and utilization management; Nexalign®, a collaborative healthcare decision support service that fosters better payer-patient-physician interactions; and InFrame™, a collaborative health information exchange service that connects care delivery organizations with one another and their patients. For more information, visit www.MEDecision.com.

MEDecision is a trademark of MEDecision, Inc. The MEDecision logo and product names are also trademarks or registered trademarks of MEDecision, Inc. Other product and brand names are trademarks of their respective owners.

Tags: MEDecision, Alineo, Alineo 3.0, healthcare, healthcare reform, MHPAEA, collaborative healthcare management, behavioral health, member-centric behavioral health utilization management, UM, case management, disease management, utilization management



CONTACT:

MEDecision
Sherri Stuart, 610-540-0202 ext. 2236
Director, Corporate Communications
[email protected]
or
TECHMarket Communications
Laura Paden, 818-597-0480
[email protected]

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Practice Management  Health  Professional Services  Insurance  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options. 

Centene announced another five states have approved its pending $17B merger with WellCare, bringing total number of approvals to 24.